Cardio Diagnostics Holdings is trading 8.6% up at $2.02, with no clear company-specific catalyst identified for September 8, 2026.

  • Recent announcements—the Iowa laboratory launch and rural cardiovascular-care report—were dated August 18 and August 26, respectively, rather than September 8.
  • Broader healthcare and major-market benchmarks are lower, so they do not clearly explain the positive move.